Paweł Wiczling

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 20

Top Topics

Patients Undergoing

High Resolution Mass Spectrometry

Abdominal Aortic

Top Venues

Analytical chemistry

Biopharmaceutics & drug disposition

Antimicrobial agents and chemotherapy

Journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Paweł Wiczling, Agnieszka Kamedulska
Comparison of Chromatographic Stationary Phases Using a Bayesian-Based Multilevel Model. Analytical chemistry 96 (3) (2024)
Paweł Wiczling, Agnieszka Kamedulska
Comparison of Chromatographic Stationary Phases Using a Bayesian-Based Multilevel Model. Analytical chemistry (2024)
Paweł Piwowarczyk, Marta Szczukocka, Wojciech Cios, Paulina Okuńska, Grzegorz Raszewski, Michał Borys, Paweł Wiczling, Mirosław Czuczwar
Population Pharmacokinetics and Probability of Target Attainment Analysis of Nadroparin in Different Stages of COVID-19. Clinical pharmacokinetics (2023)
Paweł Piwowarczyk, Marta Szczukocka, Wojciech Cios, Paulina Okuńska, Grzegorz Raszewski, Michał Borys, Paweł Wiczling, Mirosław Czuczwar
Population Pharmacokinetics and Probability of Target Attainment Analysis of Nadroparin in Different Stages of COVID-19. Clinical pharmacokinetics (2023)
Małgorzata Grześkowiak, Agnieszka Bienert, Paweł Wiczling, Mirosław Malec, Joanna Grzelak, Konrad Jarosz, Justyna Ber, Michał Książkiewicz, Jowita Rosada-Kurasińska, Edmund Grześkowiak, Alicja Bartkowska-Śniatkowska
Population Pharmacokinetic-Pharmacodynamic Modeling and Probability of Target Attainment Analysis of Rocuronium and Sugammadex in Children Undergoing Surgery. European journal of drug metabolism and pharmacokinetics (2022)
Agnieszka Kamedulska, Łukasz Kubik, Julia Jacyna, Wiktoria Struck-Lewicka, Michał J Markuszewski, Paweł Wiczling
Toward the General Mechanistic Model of Liquid Chromatographic Retention. Analytical chemistry 94 (31) (2022)
Paweł Wiczling, Agnieszka Kamedulska, Łukasz Kubik
Application of Bayesian Multilevel Modeling in the Quantitative Structure-Retention Relationship Studies of Heterogeneous Compounds. Analytical chemistry 93 (18) (2021)
Dariusz Onichimowski, Anita Będźkowska, Hubert Ziolkowski, Jerzy J Jaroszewski, Michał Borys, Mirosław Czuczwar, Paweł Wiczling
Population pharmacokinetics of standard-dose meropenem in critically ill patients on continuous renal replacement therapy: a prospective observational trial. Pharmacological reports : PR 72 (3) (2020)
Justyna Warzybok, Agnieszka Bienert, Agnieszka Borsuk-De Moor, Włodzimierz Płotek, Karolina Kulińska, Katarzyna Czerniak, Hanna Billert, Agnieszka Klupczyńska, Jan Matysiak, Edmund Grześkowiak, Paweł Wiczling
Population analysis to assess the influence of age and body weight on pharmacokinetics and pharmacodynamics of dexmedetomidine in New Zealand White rabbits. Biopharmaceutics & drug disposition 41 (7) (2020)
Agnieszka Borsuk-De Moor, Justyna Sysiak-Sławecka, Elżbieta Rypulak, Michał Borys, Paweł Piwowarczyk, Grzegorz Raszewski, Dariusz Onichimowski, Mirosław Czuczwar, Paweł Wiczling
Nonstationary Pharmacokinetics of Caspofungin in ICU Patients. Antimicrobial agents and chemotherapy 64 (9) (2020)
Justyna Ber, Paweł Wiczling, Marcin Hołysz, Agnieszka Klupczyńska, Alicja Bartkowska-Śniatkowska, Krzysztof Bieda, Piotr Smuszkiewicz, Małgorzata Nowicka, Łukasz Żurański, Paweł Sobczyński, Jan Matysiak, Edmund Grześkowiak, Agnieszka Bienert
Population Pharmacokinetic Model of Dexmedetomidine in a Heterogeneous Group of Patients. Journal of clinical pharmacology 60 (11) (2020)
Damian Szczesny, Katarzyna Mołoniewicz, Michał J Markuszewski, Paweł Wiczling
Proof-of-concept study on improved efficacy of rHuEPO administered as a long-term infusion in rats. Pharmacological reports : PR 72 (5) (2020)
Paweł Wiczling, Emilia Daghir-Wojtkowiak, Roman Kaliszan, Michał Jan Markuszewski, Janusz Limon, Magdalena Koczkowska, Maciej Stukan, Alina Kuźniacka, Magdalena Ratajska
Bayesian multilevel model of micro RNA levels in ovarian-cancer and healthy subjects. PloS one 14 (8) (2019)
Agnieszka Borsuk-De Moor, Elżbieta Rypulak, Beata Potręć, Paweł Piwowarczyk, Michał Borys, Justyna Sysiak, Dariusz Onichimowski, Grzegorz Raszewski, Mirosław Czuczwar, Paweł Wiczling
Population Pharmacokinetics of High-Dose Tigecycline in Patients with Sepsis or Septic Shock. Antimicrobial agents and chemotherapy 62 (4) (2018)
Łukasz Kubik, Roman Kaliszan, Paweł Wiczling
Analysis of Isocratic-Chromatographic-Retention Data using Bayesian Multilevel Modeling. Analytical chemistry 90 (22) (2018)
Emilia Daghir-Wojtkowiak, Paweł Wiczling, Małgorzata Waszczuk-Jankowska, Roman Kaliszan, Michał Jan Markuszewski
Multilevel pharmacokinetics-driven modeling of metabolomics data. Metabolomics : Official journal of the Metabolomic Society 13 (3) (2017)
Agnieszka Borsuk, Bogumiła Wołoszczuk-Gębicka, Alicja Bartkowska-Śniatkowska, Jowita Rosada-Kurasińska, Agnieszka Bienert, Paweł Wiczling
Flip-Flop Phenomenon in Epidural Sufentanil Pharmacokinetics: A Population Study in Children and Infants. Journal of clinical pharmacology 57 (9) (2017)
Paweł Wiczling, Krzysztof Bieda, Krzysztof Przybyłowski, Roma Hartmann-Sobczyńska, Agnieszka Borsuk, Jan Matysiak, Zenon J Kokot, Paweł Sobczyński, Edmund Grześkowiak, Agnieszka Bienert
Pharmacokinetics and pharmacodynamics of propofol and fentanyl in patients undergoing abdominal aortic surgery - a study of pharmacodynamic drug-drug interactions. Biopharmaceutics & drug disposition 37 (5) (2017)
Paweł Wiczling, Emilia Daghir-Wojtkowiak, Arlette Yumba Mpanga, Damian Szczesny, Roman Kaliszan, Michał Jan Markuszewski
How to model temporal changes in nontargeted metabolomics study? A Bayesian multilevel perspective. Journal of separation science 40 (24) (2017)
Piotr Smuszkiewicz, Paweł Wiczling, Krzysztof Przybyłowski, Agnieszka Borsuk, Iwona Trojanowska, Marta Paterska, Jan Matysiak, Zenon J Kokot, Edmund Grześkowiak, Agnieszka Bienert
The pharmacokinetics of propofol in ICU patients undergoing long-term sedation. Biopharmaceutics & drug disposition 37 (8) (2016)